Monitoring Before, During, and After Treatment

Module number
 
Date presented
November 12, 2019 
Duration
52:00 
Audience
 
CE Credit
ELF 

On Tuesday, November 12th Dr. Lisa Ganjhu of NYU Langone School of Medicine presented on:

“Monitoring Before, During, and After Treatment”

Learning Objectives

  1. Describe the appropriate evaluation prior to initiation of DAA therapy.
  2. Discuss the process for obtaining DAA approval from payors.
  3. Recognize the appropriate monitoring on DAA therapy.
  4. Describe the appropriate monitoring following treatment with DAA therapy.

Presenter Bio:

Dr. Lisa Ganjhu earned her medical degree from New York College of Osteopathic Medicine and completed her internal medicine residency and gastroenterology fellowship at Albany Medical Center. She went on to do an advanced fellowship in Liver and Transplant Medicine at Mt Sinai Medical Center in NYC.  Dr Ganjhu is a Clinical Associate Professor of Medicine in the Division Gastroenterology and Hepatology at NYU Langone Health. She is an active member of the Empire Liver foundation in NYC. Besides the management viral hepatitis, her focus is a lifestyle approach to the management of NASH/NAFLD.

Access the slides here